It’s just my opinion ….. and that is whether we get FDA approval or not (either way) with an FDA approval big pharma will more than likely want to own the paradigm shift in medical treatments and without an FDA approval they are likely to want to pick up the pieces / patents and go for it with much bigger resources at their disposal ….
…… don’t run out and buy shares on my takeover opinion though, as it is exactly that … my opinion of what will transpire this year as we really are at the pointy end in multiple indications …… I did however predict for the last 2 years that the FDA would entertain an AA pathway for Rexlemestrocel-L for CHF so there is that … lol
Ann: Appendix 3Y for Jane Bell, page-29
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.000(0.00%) |
Mkt cap ! $1.267B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.13 | $1.06 | $12.24M | 11.22M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32118 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 21178 | 2 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.10 |
Change
0.000 ( 2.07 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.12 | $1.06 | 1826006 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| MSB (ASX) Chart |